AB&B BIO-TECH-B
0262718AListed醫療健康 · 一家中国疫苗公司，专注于创新疫苗及传统疫苗的研发、制造和商业化。
High attention
78
/100
- Offer price
- HK$12.90
- Final offer price
- HK$12.90
- Lot / entry fee
- 200 shares · HK$3K
- Proceeds
- HK$431.4M
- Sponsor
- CITIC Securities / CMB International
- Est. margin oversub.
- 3398.4x
- Public oversub.
- 4007.6x
- One-lot win rate
- 1.0%
- First-day return
- +158.0%
Offer starts
Jul 31
Offer closes
Aug 5
Grey market
Aug 8
Listing
Aug 11
AI reference scoring and scenarios
After grey market
After grey market L1 heat score
78/ 100
Data coverage Mid-high
Target
Prior calibration
Listing-day trend
PositivePartial basis
Up probability
76.0%
First-day reference range
+157.6% – +243.6%
Published outcome check
First-day resultBig up+158.0%
Our call: Trend call valid
Covered 13/25 core factors
UsedMissingNot yet scorableN/A
Margin oversubscription
High heatOffer size
Good qualityCornerstone lockup
—Post-lockup offer value
—Recent same-rule trend
—Recent same-type trend
—Recent sector trend
—Valuation
Average appealFundamental quality
Average qualityGrowth quality
Weak qualityProfitability
Weak qualityCash runway
High qualityCustomer concentration
High riskCornerstone quality
—Sponsor record
—Greenshoe arrangementNo greenshoe
Stabilizer track record
—A-share pre-grey trend
—A-share listing-day trend
—Public oversubscription
High heatOne-lot win rate
High heatInternational placing
Low heatFinal pricing position
—Actual greenshoe use
—Grey market return
Strong trendThe assessment and probability ranges are informational only and are not investment advice.
AI Research Report
After grey marketThe analysis report for this IPO is being generated.